Rhode Island SB 2535: AN ACT RELATING TO BUSINESSES AND PROFESSIONS - PRESCRIPTION DRUG SALES - REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative and to pay an annual fee for each name listed with the department of business regulation.)

Status: 03/27/2018 Committee recommended measure be held for further study (as of 2018-03-27)

State: Rhode Island · Session: 2018 · Bill: SB 2535

Subjects: Business & Professions, Fees, Prescription drugs

Sponsors: Calkin, Goldin, Miller, Raptakis, Satchell

View Rhode Island SB 2535 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.